Global Insulin Glargine Market Size is projected to reach USD 2200 million by 2031, growing at a CAGR of 6.11%: Straits Research
March 20, 2024 10:50 ET
|
Straits Research Private Limited - Reed Intelligence
New York, United States, March 20, 2024 (GLOBE NEWSWIRE) -- Insulin glargine is a modified, long-acting form of medical insulin used to treat diabetes types I and II. It is subcutaneously injected....